genOway S.A.
PAR: ALGEN.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Alexandre Fraichard
- Employees
- 124
- Headquarters
- Lyon, France
- IPO year
- 2007
- Market cap
- €22.8M
- Website
- https://www.genoway.com
Loading ALGEN…
Loading profile data…Frequently asked questions about ALGEN
What does genOway S.A. (ALGEN.PA) do?
genOway Société anonyme, a biotechnology company, develops, manufactures, commercializes, and sells of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation K...
Where does ALGEN.PA trade?
genOway S.A. (ALGEN.PA) trades on the Euronext Paris.
What sector is ALGEN.PA in?
genOway S.A. (ALGEN.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of genOway S.A.?
Alexandre Fraichard is the chief executive officer of genOway S.A. (ALGEN.PA).
Where is genOway S.A. headquartered?
genOway S.A. is headquartered in France.
Does ALGEN.PA pay a dividend?
genOway S.A. (ALGEN.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALGEN.PA go public?
genOway S.A. (ALGEN.PA) completed its initial public offering in 2007.